Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

December 22, 2025 — Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is back in the spotlight as its stock price whipsaws following a sharp late-week surge and a fresh round of market commentary that mixes optimism about the company’s muscle-disease pipeline with familiar concerns about cash burn in a pre-revenue biotech. As of 18:40 UTC on Dec. 22, EWTX traded at $21.29, after swinging between $27.77 and $21.18 intraday, with volume running well above a million shares. Below is a complete, news-style breakdown of the current coverage and forecasts circulating on Dec. 22, 2025, plus the trial and business milestones investors are
Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025)

Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025)

Twist Bioscience Corporation (NASDAQ: TWST) is ending 2025 with something investors in “tools + genomics” names haven’t always been able to count on: momentum that’s tied to multiple moving pieces—new product launches, partner-driven workflow wins, and a profitability narrative that’s finally getting sharper edges. On December 22, 2025, TWST shares were trading around $34.26, up about 5.4% on the session at the time of writing (midday U.S. trading). MarketScreener That pop isn’t happening in a vacuum. Over the past few weeks, the company has stacked up incremental catalysts—from a fresh licensing deal touching NGS and hot-start PCR, to product expansion
Sunrun Stock (NASDAQ: RUN) Jumps on Dec. 22, 2025: Tax-Credit Deadline, Analyst Targets, and the NRG Partnership in Focus

Sunrun Stock (NASDAQ: RUN) Jumps on Dec. 22, 2025: Tax-Credit Deadline, Analyst Targets, and the NRG Partnership in Focus

Sunrun Inc. (NASDAQ: RUN) is back in the spotlight on December 22, 2025, with shares trading sharply higher as investors weigh a fast-approaching U.S. residential solar tax-credit cutoff, a fresh wave of bullish (and less-bearish) Wall Street commentary, and new momentum around Sunrun’s grid-services strategy. By early afternoon, RUN was trading around $19.7–$19.8, up roughly 8% on the day after a prior close near $18.26, with the session range pushing up toward roughly $20. Investing.com+2Finviz+2 That single-day move matters because it’s landing in the middle of a bigger story: Sunrun’s business model is increasingly being priced as a policy-and-financing play
Viasat (VSAT) Stock Today: Price Jumps as ViaSat-3 Expansion, Ka-Band Defense Network, and Analyst Forecasts Shape 2026 Outlook (Dec. 22, 2025)

Viasat (VSAT) Stock Today: Price Jumps as ViaSat-3 Expansion, Ka-Band Defense Network, and Analyst Forecasts Shape 2026 Outlook (Dec. 22, 2025)

Viasat, Inc. (NASDAQ: VSAT) shares were trading around $36.16 on Monday, December 22, 2025, up roughly 7% from the prior close—another sharp move in what has been a highly eventful year for the satellite communications company and its investors. MarketScreener The latest momentum comes as Wall Street continues to weigh three big themes around Viasat stock: Below is a complete, up-to-date breakdown of the most relevant news, forecasts, and analyst thinking available as of Dec. 22, 2025. Viasat stock price on Dec. 22, 2025: what the market is doing right now By midday on Dec. 22, VSAT was quoted near
Planet Labs Stock (PL) Surges on Dec. 22, 2025: Record Revenue, Raised FY2026 Outlook, Analyst Targets, and What Comes Next

Planet Labs Stock (PL) Surges on Dec. 22, 2025: Record Revenue, Raised FY2026 Outlook, Analyst Targets, and What Comes Next

Planet Labs PBC (NYSE: PL) is back in the market spotlight on Monday, December 22, 2025, as the stock trades near record territory after a cascade of catalysts: a blowout fiscal Q3 revenue print, sharply higher contract backlog metrics, fresh satellite milestones for its next‑gen Pelican fleet, and a wave of analyst price‑target revisions. Investing.com+1 By midday, PL was up strongly on the session after closing the prior trading day at $19.18, with intraday trading pushing above $20—a level that underscores how dramatically investor sentiment has shifted since earlier in 2025. Investing.com PL stock today: the price action driving headlines
Exzeo Group (NYSE: XZO) Stock News, Forecasts and Analysis for Dec. 22, 2025: Shares Hit a New High as Wall Street Coverage Builds

Exzeo Group (NYSE: XZO) Stock News, Forecasts and Analysis for Dec. 22, 2025: Shares Hit a New High as Wall Street Coverage Builds

Exzeo Group, Inc. (NYSE: XZO) stock is back in the spotlight on Dec. 22, 2025, after pushing to a fresh 12‑month (52‑week) high in Monday trading—an attention-grabbing move for a company that only recently arrived on the public markets. MarketBeat The timing matters. Since its November IPO, Exzeo has rolled out a strong first post‑IPO earnings report, management has issued new operating and profit targets, and multiple firms have initiated research coverage with price targets clustered in the mid‑to‑high $20s. Put together, it’s a classic “new IPO momentum + fundamentals + first wave of analyst models” setup—exciting, but also the
Globalstar Stock (GSAT) Surges on Dec. 22, 2025: Latest News, Apple Partnership, Analyst Targets, and What Investors Are Watching Next

Globalstar Stock (GSAT) Surges on Dec. 22, 2025: Latest News, Apple Partnership, Analyst Targets, and What Investors Are Watching Next

Globalstar, Inc. (NASDAQ: GSAT) is back in motion on Monday, December 22, 2025, with the satellite-and-spectrum name seeing a notable bounce after a choppy mid-December pullback. As of the latest available trading data, GSAT was trading around the mid-$60s per share, up roughly 6%–7% on the day, after moving between the low-$60s and upper-$60s intraday. StockAnalysis+1 That pop isn’t happening in a vacuum. Over the past several weeks, Globalstar has stacked up a headline cocktail that investors love and fear in equal measure: Apple-linked satellite connectivity, private 5G ambitions using Band n53, fresh analyst coverage and price targets, and lingering
Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is having one of those classic biotech days where the market starts acting like it can see the future. On Monday, December 22, 2025, ZBIO surged roughly 14% and traded around $41.23 by early afternoon Eastern time—after touching a fresh all-time high near $41.67, according to multiple market data reports. MarketBeat+1 The timing isn’t subtle: Zenas is approaching a pivotal clinical-data moment for its lead asset obexelimab, and Wall Street research desks are increasingly framing the stock as a near-term catalyst setup—high potential reward, high potential whiplash. Below is a full roundup of the news,
Polestar Automotive Holding (PSNY) Stock Jumps After New Funding: Today’s News, Forecasts, and Analyst Views (Dec. 22, 2025)

Polestar Automotive Holding (PSNY) Stock Jumps After New Funding: Today’s News, Forecasts, and Analyst Views (Dec. 22, 2025)

Polestar Automotive Holding UK PLC (NASDAQ: PSNY) is back in the spotlight on Monday, December 22, 2025, as investors react to a fresh liquidity package anchored by its majority owner Geely—plus new bank money and a debt-to-equity conversion. By midday in New York, PSNY stock traded around $14.18, up roughly 10.9% from the prior close after opening near $12.94 and swinging between $12.80 and $14.39.Swedish newswire coverage also noted the stock popped at the open following the weekend’s financing headlines. Omni What’s driving the move is not one announcement, but a sequence of balance-sheet and funding actions over the past
Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) is in the spotlight on December 22, 2025, after the company confirmed it has agreed to be acquired in an all-cash take-private transaction valued at about $8.4 billion (including debt). Shareholders are set to receive $24.55 per share in cash, a headline number that has quickly become the market’s “gravity well” for the stock. Reuters+2CWAN+2 With the deal now public, the CWAN story shifts from the usual quarterly beat/miss drama to a more deal-driven narrative: merger timelines, regulatory approvals, a “go-shop” window for competing bids, and whether the stock trades at (or below) the
Karman Holdings (KRMN) Stock Surges on Dec. 22, 2025: What Today’s Rally, New Forecasts, and the Five Axis Deal Mean for Investors

Karman Holdings (KRMN) Stock Surges on Dec. 22, 2025: What Today’s Rally, New Forecasts, and the Five Axis Deal Mean for Investors

Karman Holdings Inc. (NYSE: KRMN) stock is having a loud Monday. In midday trading on December 22, 2025, KRMN stock jumped roughly 8%–9% into the high-$70s, putting the aerospace-and-defense newcomer among the market’s notable winners as risk appetite improved and small caps outperformed. StockAnalysis+2Benzinga+2 So what’s actually behind the move—and what do the newest forecasts and analyses imply for where Karman Holdings stock could go next? Below is a comprehensive snapshot of today’s news and analysis (Dec. 22, 2025), plus the freshest Wall Street outlooks that are shaping the narrative around KRMN right now. KRMN stock today: price, momentum, and
Rocket Lab (RKLB) Stock Surges on $816M Space Force Satellite Contract and Record 2025 Launches — What News and Forecasts Say on Dec. 22, 2025

Rocket Lab (RKLB) Stock Surges on $816M Space Force Satellite Contract and Record 2025 Launches — What News and Forecasts Say on Dec. 22, 2025

Rocket Lab Corporation stock (NASDAQ: RKLB) is starting the holiday-shortened week with a bang: shares pushed to fresh highs on Monday, December 22, 2025, extending a sharp rally that began late last week. The move follows two closely linked catalysts that investors tend to love in the same sentence: a “landmark” U.S. national security satellite contract and a record-setting year of flawless Electron launches. Investopedia+2Investors+2 Depending on the outlet and the moment measured, Rocket Lab stock was up mid-to-high single digits on Dec. 22 after jumping roughly 18% on Friday (Dec. 19)—momentum fueled by contract headlines and a weekend launch
1 569 570 571 572 573 884

Stock Market Today

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Glencore share price steadies after Rio Tinto walks away — what to watch next week

Glencore share price steadies after Rio Tinto walks away — what to watch next week

7 February 2026
Glencore shares closed up 0.6% at 478.1 pence Friday, rebounding after a 7% drop following the collapse of merger talks with Rio Tinto. The company is expected to announce the sale of its Kazzinc stake soon and has signed a non-binding agreement with Orion for a potential $9 billion deal in the DRC. Investors await Glencore’s full-year results on Feb. 18 for further guidance.
Go toTop